134 related articles for article (PubMed ID: 10481784)
1. Molecular pathogenesis of pituitary adenomas: a review.
Suhardja AS; Kovacs KT; Rutka JT
Acta Neurochir (Wien); 1999; 141(7):729-36. PubMed ID: 10481784
[TBL] [Abstract][Full Text] [Related]
2. Genetic basis of pituitary adenoma invasiveness: a review.
Suhardja A; Kovacs K; Rutka J
J Neurooncol; 2001 May; 52(3):195-204. PubMed ID: 11519849
[TBL] [Abstract][Full Text] [Related]
3. Genesis of pituitary adenomas: state of the art.
Faglia G; Spada A
J Neurooncol; 2001 Sep; 54(2):95-110. PubMed ID: 11761437
[TBL] [Abstract][Full Text] [Related]
4. [Molecular basis of pituitary adenomas with emphasis on somatotropinomas].
Donangelo I; Gadelha M
Arq Bras Endocrinol Metabol; 2004 Aug; 48(4):464-79. PubMed ID: 15761509
[TBL] [Abstract][Full Text] [Related]
5. Oncogene activation in pituitary tumors.
Yu R; Melmed S
Brain Pathol; 2001 Jul; 11(3):328-41. PubMed ID: 11414475
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology of pituitary adenomas.
Lloyd RV
J Neurooncol; 2001 Sep; 54(2):111-9. PubMed ID: 11761428
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
Simpson DJ; Frost SJ; Bicknell JE; Broome JC; McNicol AM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Aug; 22(8):1149-54. PubMed ID: 11470742
[TBL] [Abstract][Full Text] [Related]
8. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
9. [Genetic changes in human pituitary adenomas].
Spada A; Lania A
Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenoma pathogenesis: an update.
Rostad S
Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):322-7. PubMed ID: 22617628
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor loss in pituitary tumors.
Alexander JM
Brain Pathol; 2001 Jul; 11(3):342-55. PubMed ID: 11414476
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of pituitary tumors.
Farrell WE; Clayton RN
Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
[TBL] [Abstract][Full Text] [Related]
13. [Molecular aspects of pituitary tumorigenesis].
Pinto EM; Bronstein MD
Arq Bras Endocrinol Metabol; 2008 Jun; 52(4):599-610. PubMed ID: 18604372
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of pituitary tumor transforming gene in tumorigenesis.
Tfelt-Hansen J; Kanuparthi D; Chattopadhyay N
Clin Med Res; 2006 Jun; 4(2):130-7. PubMed ID: 16809406
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I
Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
17. Cellular alterations in pituitary tumors.
Spada A; Vallar L; Faglia G
Eur J Endocrinol; 1994 Jan; 130(1):43-52. PubMed ID: 7907260
[TBL] [Abstract][Full Text] [Related]
18. Oncogenesis and mutagenesis of pituitary tumors.
Sonabend AM; Musleh W; Lesniak MS
Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S3-14. PubMed ID: 17004855
[TBL] [Abstract][Full Text] [Related]
19. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
20. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
